Andere Kunden interessierten sich auch für
![The Modern Era of Coronary Thrombolysis]( "The Modern Era of Coronary Thrombolysis")
The Modern Era of Coronary Thrombolysis147,99 €![Textbook of Coronary Thrombosis and Thrombolysis]( "Textbook of Coronary Thrombosis and Thrombolysis")
Textbook of Coronary Thrombosis and Thrombolysis374,99 €![Transluminal Coronary Angioplasty and Intracoronary Thrombolysis]( "Transluminal Coronary Angioplasty and Intracoronary Thrombolysis")
Transluminal Coronary Angioplasty and Intracoronary Thrombolysis83,99 €![Thrombosis and Cardiovascular Diseases]( "Thrombosis and Cardiovascular Diseases")
Thrombosis and Cardiovascular Diseases83,99 €![Myocardial Infarction at Young Age]( "Myocardial Infarction at Young Age")
Myocardial Infarction at Young Age83,99 €![Expanding Horizons in Atherosclerosis Research]( "Expanding Horizons in Atherosclerosis Research")
Expanding Horizons in Atherosclerosis Research83,99 €![Predisposing Conditions for Acute Ischemic Syndromes]( "Predisposing Conditions for Acute Ischemic Syndromes")
Predisposing Conditions for Acute Ischemic Syndromes37,99 €
Coronary heart disease remains the leading cause of death for men and women in the United States and other industrialized nations. Acute myocardial infarction accounts for a majority of these deaths, approaching 750,000 yearly.
Thrombolytic therapy has revolutionized the treatment of myocardial infarction, saving lives to a greater extent than any treatment developed to date. The identification of patients best suited for thrombolytic therapy has been a challenging task, as has the ideal adjuvant strategy. Further, the noninvasic diagnosis of treatment successes and failures, as well as the expeditious triaging of patients requiring mechanical/surgical revascularization have been difficult to define, but progress has been made recently.
The emergence of information vital for patient care has appeared at an extraordinary pace, with hundreds of articles being published yearly. Unfortunately, a resource devoted to the area of thrombolysis does not exist, making the dissemination of information to physicians, scientists and health care providers problematic.
The Modern Era of Coronary Thrombolysis is designed to bring the medical and scientific communities up to date. It will serve as a foundation for future investigation, as well as a resource which can be referred to for many years to come.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Thrombolytic therapy has revolutionized the treatment of myocardial infarction, saving lives to a greater extent than any treatment developed to date. The identification of patients best suited for thrombolytic therapy has been a challenging task, as has the ideal adjuvant strategy. Further, the noninvasic diagnosis of treatment successes and failures, as well as the expeditious triaging of patients requiring mechanical/surgical revascularization have been difficult to define, but progress has been made recently.
The emergence of information vital for patient care has appeared at an extraordinary pace, with hundreds of articles being published yearly. Unfortunately, a resource devoted to the area of thrombolysis does not exist, making the dissemination of information to physicians, scientists and health care providers problematic.
The Modern Era of Coronary Thrombolysis is designed to bring the medical and scientific communities up to date. It will serve as a foundation for future investigation, as well as a resource which can be referred to for many years to come.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.